Literature DB >> 18017912

Field Evaluation of a Human Anthrax Vaccine.

P S Brachman, H Gold, S A Plotkin, F R Fekety, M Werrin, N R Ingraham.   

Abstract

Entities:  

Year:  1962        PMID： 18017912      PMCID： PMC1522900          DOI： 10.2105/ajph.52.4.632

Source DB:  PubMed          Journal:  Am J Public Health Nations Health        ISSN： 0002-9572


× No keyword cloud information.
  10 in total

1.  An epidemic of inhalation anthrax: the first in the twentieth century. II. Epidemiology.

Authors:  P S BRACHMAN; S A PLOTKIN; F H BUMFORD; M M ATCHISON
Journal:  Am J Hyg       Date:  1960-07

2.  Industrial anthrax.

Authors:  P S BRACHMAN; F R FEKETY
Journal:  Ann N Y Acad Sci       Date:  1958-06-03       Impact factor: 5.691

3.  The use of anthrax antigen to immunise man and monkey.

Authors:  F C BELTON; H M DARLOW; D W HENDERSON
Journal:  Lancet       Date:  1956-09-08       Impact factor: 79.321

4.  Studies on immunity in anthrax. V. Immunizing activity of alum-precipitated protective antigen.

Authors:  G G WRIGHT; T W GREEN; R G KANODE
Journal:  J Immunol       Date:  1954-12       Impact factor: 5.422

5.  Studies on immunity in anthrax. IV. Factors influencing elaboration of the protective antigen of bacillus antracis in chemically defined media.

Authors:  M PUZISS; G G WRIGHT
Journal:  J Bacteriol       Date:  1954-10       Impact factor: 3.490

6.  Anthrax; a report of one hundred seventeen cases.

Authors:  H GOLD
Journal:  AMA Arch Intern Med       Date:  1955-09

7.  Studies on immunity in anthrax. III. Elaboration of protective antigen in a chemically defined, non-protein medium.

Authors:  G G WRIGHT; M A HEDBERG; J B SLEIN
Journal:  J Immunol       Date:  1954-04       Impact factor: 5.422

8.  Studies on immunity in anthrax. VI. Immunizing activity of protective antigen against various strains of Bacillus anthracis.

Authors:  S AUERBACH; G G WRIGHT
Journal:  J Immunol       Date:  1955-08       Impact factor: 5.422

9.  Studies on immunity in anthrax. I. Variation in the serum T-agglutinin during anthrax infection in the rabbit.

Authors:  G G WRIGHT; J B SLEIN
Journal:  J Exp Med       Date:  1951-02       Impact factor: 14.307

10.  Studies on immunity in anthrax. II. In vitro elaboration of protective antigen by non-proteolytic mutants of Bacillus anthracis.

Authors:  G G WRIGHT; M A HEDBERG; R J FEINBERG
Journal:  J Exp Med       Date:  1951-06       Impact factor: 14.307
  10 in total
  82 in total

1.  Search for correlates of protective immunity conferred by anthrax vaccine.

Authors:  S Reuveny; M D White; Y Y Adar; Y Kafri; Z Altboum; Y Gozes; D Kobiler; A Shafferman; B Velan
Journal:  Infect Immun       Date:  2001-05       Impact factor: 3.441

2.  Early statistical detection of anthrax outbreaks by tracking over-the-counter medication sales.

Authors:  Anna Goldenberg; Galit Shmueli; Richard A Caruana; Stephen E Fienberg
Journal:  Proc Natl Acad Sci U S A       Date:  2002-04-16       Impact factor: 11.205

3.  From woolsorters to mail sorters: anthrax past, present, and future.

Authors:  Victor Sidel; Hillel W Cohen; Robert M Gould
Journal:  Am J Public Health       Date:  2002-05       Impact factor: 9.308

4.  Pulmonary Manifestations of Bioterrorism.

Authors:  Renuka Heddurshetti; Wadchara Pumpradit; Larry I. Lutwick
Journal:  Curr Infect Dis Rep       Date:  2001-06       Impact factor: 3.725

5.  Modeling the optimum duration of antibiotic prophylaxis in an anthrax outbreak.

Authors:  Ron Brookmeyer; Elizabeth Johnson; Robert Bollinger
Journal:  Proc Natl Acad Sci U S A       Date:  2003-07-30       Impact factor: 11.205

Review 6.  Development of an improved vaccine for anthrax.

Authors:  Stephen H Leppla; John B Robbins; Rachel Schneerson; Joseph Shiloach
Journal:  J Clin Invest       Date:  2002-07       Impact factor: 14.808

7.  Large-scale production of protective antigen of Bacillus anthracis in anaerobic cultures.

Authors:  M PUZISS; L C MANNING; J W LYNCH; I ABELOW; G G WRIGHT
Journal:  Appl Microbiol       Date:  1963-07

8.  Bioterrorism and compulsory vaccination.

Authors:  Tom Jefferson
Journal:  BMJ       Date:  2004-09-04

9.  Phase 1 study of a recombinant mutant protective antigen of Bacillus anthracis.

Authors:  Joseph A Bellanti; Feng-Ying C Lin; Chiayung Chu; Joseph Shiloach; Stephen H Leppla; German A Benavides; Arthur Karpas; Mahtab Moayeri; Chunyan Guo; John B Robbins; Rachel Schneerson
Journal:  Clin Vaccine Immunol       Date:  2011-12-21

10.  Anthrax protective antigen delivered by Salmonella enterica serovar Typhi Ty21a protects mice from a lethal anthrax spore challenge.

Authors:  Manuel Osorio; Yanping Wu; Sunil Singh; Tod J Merkel; Siba Bhattacharyya; Milan S Blake; Dennis J Kopecko
Journal:  Infect Immun       Date:  2009-01-29       Impact factor: 3.441
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.